{"id":70026,"date":"2026-08-25T04:21:17","date_gmt":"2026-08-25T04:21:17","guid":{"rendered":"https:\/\/www.europesays.com\/news\/70026\/"},"modified":"2026-08-25T04:21:17","modified_gmt":"2026-08-25T04:21:17","slug":"oura-is-reportedly-eyeing-a-september-ipo-that-could-value-it-at-more-than-16b","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/news\/70026\/","title":{"rendered":"Oura is reportedly eyeing a September IPO that could value it at more than $16B"},"content":{"rendered":"

Oura, the smart ring maker, with offices in San Francisco and Finland, is reportedly planning to raise up to $3 billion as soon as next month in a U.S. IPO that values the more than 900-person<\/a> company at [spits out coffee] north of $16 billion<\/a>, according to Bloomberg. The outlet adds that investors are expected to sell a major chunk of stock in the offering.<\/p>\n

A $16 billion valuation would mark an enormous jump from the $10.9 billion valuation Oura was assigned last September, when it closed an $875 million Series E<\/a> round backed by Fidelity, ICONIQ, Whale Rock, and Atreides, joining earlier backers like Dexcom, The Chernin Group, Forerunner Ventures, Coatue, and Temasek.<\/p>\n

The wearables space has gotten crowded fast. <\/p>\n

Samsung launched its own ring, the Galaxy Ring, two years ago. But Oura\u2019s most direct rival may be the fitness band maker Whoop, which has undergone its own reinvention. Once a performance tool for elite athletes and young men, Whoop has spent the past year courting a much broader audience, layering in hormone tracking and blood-panel testing for perimenopause and thyroid health. The move drove its own valuation up to $10 billion<\/a> back in March. Oura has followed a similar path, evolving from its starting niche of biohacking CEOs into a more mainstream sleep-and-recovery brand.<\/p>\n

Oura announced in May<\/a> that it had filed confidentially for an IPO.<\/p>\n

The company has said that it generated $500 million in revenue in 2024, roughly $1 billion in 2025, and that it expected to generate close to $2 billion<\/a> in revenue in 2026, though we\u2019ll learn much more once its S-1 filing becomes publicly available.<\/p>\n

Not all of Oura\u2019s recent attention has been positive. A proposed class action lawsuit filed last week<\/a> in San Francisco is accusing Oura of misleading consumers about the accuracy of its sleep tracking features. Among other complaints<\/a> in the filing, Oura is accused of not just claiming \u201cto measure a heartbeat or a temperature, but the exact stage of sleep the wearer is in\u2014which in reality requires electrodes in the scalp and sensors on the eyes, as only a hospital or other clinical setting can do.\u201d<\/p>\n

In a statement to TechCrunch sent over the weekend, a spokesperson pushed back against claims in that suit, saying the company plans to \u201cdefend against them in the appropriate legal forum\u201d and that \u201c[w]hile Oura Ring is not a medical device or a substitute for a clinical sleep study, Oura\u2019s sleep staging has been validated and compared favorably in multiple studies against polysomnography, the gold standard.\u201d The statement continued on to say that \u201c[m]ultiple third-party, independent studies support our claims of accuracy and we have transparently reported on the mechanisms and measures that inform Oura\u2019s sleep staging.\u201d<\/p>\n

When you purchase through links in our articles, we may earn a small commission<\/a>. This doesn\u2019t affect our editorial independence.<\/p>\n","protected":false},"excerpt":{"rendered":"Oura, the smart ring maker, with offices in San Francisco and Finland, is reportedly planning to raise up…\n","protected":false},"author":2,"featured_media":70027,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4],"tags":[8,2833,9,36288,7],"class_list":["post-70026","post","type-post","status-publish","format-standard","has-post-thumbnail","category-top-stories","tag-headlines","tag-ipo","tag-news","tag-oura","tag-top-stories"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@news\/117154236488518235","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/posts\/70026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/comments?post=70026"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/posts\/70026\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/media\/70027"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/media?parent=70026"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/categories?post=70026"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/news\/wp-json\/wp\/v2\/tags?post=70026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}